Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | YTHDF2 | Q9Y5A9 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30517206 | 0.98 | KMT2A (0.50) | KMT2AMEN1YTHDF2LMNAPABPC1 | |
| SCHEMBL2632820 | 0.74 | YTHDF2 (0.52) | KMT2AMEN1YTHDF2LMNAPABPC1 | |
| SCHEMBL2632919 | 0.74 | MEN1 (0.57) | KMT2AMEN1YTHDF2LMNAPABPC1 | |
| SCHEMBL3297433 | 0.74 | KMT2A (0.54) | KMT2AMEN1LMNASMN1; SMN2GAA | |
| SCHEMBL15038565 | 0.73 | KMT2A (0.44) | KMT2AMEN1LMNASMN1; SMN2GAA | |
| SCHEMBL10281144 | 0.73 | YTHDF2 (0.50) | KMT2AMEN1YTHDF2LMNAPABPC1 | |
| SCHEMBL12432833 | 0.73 | YTHDF2 (0.50) | KMT2AMEN1YTHDF2LMNAPABPC1 | |
| SCHEMBL1947779 | 0.73 | YTHDF2 (0.50) | KMT2AMEN1YTHDF2LMNAPABPC1 | |
| SCHEMBL10855053 | 0.72 | CYP3A4 (0.50) | KMT2ASMN1; SMN2GAAALDH1A1PGR | |
| SCHEMBL220200 | 0.72 | KMT2A (0.57) | KMT2AMEN1LMNASMN1; SMN2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 537 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036725-A | Method for preparing denitrification flavin second generation | 山东丰金制药有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4560315-A2 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. Hoffmann-La Roche AG (CH) | 2025-05-28 | — | — | EP | claimed |
| EP-3980554-B1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | HOFFMANN LA ROCHE (CH) | 2025-03-26 | — | — | EP | claimed |
| CN-118063396-A | Preparation method of 6-chloro-3-methyl uracil | 黑龙江立科新材料有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-112939937-B | Synthesis process of trelagliptin succinate | 合肥工业大学 | 2023-09-22 | — | — | CN | claimed |
| CN-116143748-A | Preparation method of trelagliptin succinate related substances | 浙江燎原药业有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-115536597-A | Preparation method of high-purity alogliptin benzoate intermediate | 山东新华制药股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| US-20220195497-A1 | HYBRIDIZING all-LNA OLIGONUCLEOTIDES | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2022-06-23 | — | — | US | claimed |
| CN-111693627-B | Detection method and application of 6-chloro-3-methyl uracil and related substances thereof | 山西振东制药股份有限公司 | 2022-05-13 | — | — | CN | claimed |
| EP-3980554-A1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. Hoffmann-La Roche AG (CH) | 2022-04-13 | — | — | EP | claimed |
| CN-105968091-A | Method for preparing drug Alogliptin for treating diabetes type II | 青岛辰达生物科技有限公司 | 2016-09-28 | — | — | CN | claimed |
| CN-104151291-B | A kind of preparation method of SYR-322 polymorph crystals | JIANGSU DEYUAN PHARMACEUTICAL CO., LTD. (CN) | 2016-01-20 | — | — | CN | claimed |
| CN-104961726-A | Preparation method of trelagliptin | ZHEJIANG YONGNING PHARMA CO LTD | 2015-10-07 | — | — | CN | claimed |
| WO-2015092739-A1 | PROCESS FOR PREPARATION OF ALOGLIPTIN | Mylan Laboratories Ltd. (IN) | 2015-06-25 | — | — | WO | claimed |
| WO-2015092807-A1 | A NOVEL PROCESS FOR PREPARATION OF ALOGLIPTIN BENZOATE | HARMAN FINOCHEM LIMITED (IN) | 2015-06-25 | — | — | WO | claimed |
| CN-104193726-A | Synthesis method of alogliptin benzoate | JIANGSU DEYUAN PHARMACEUTICAL CO LTD | 2014-12-10 | — | — | CN | claimed |
| CN-104151253-A | Synthesis method of Alogliptin intermediate | SICHUAN TONGSHENG BIOTECHNOLOGY CO LTD | 2014-11-19 | — | — | CN | claimed |
| CN-104151291-A | Preparation method for benzoic acid alogliptin polycrystalline type crystal | JIANGSU DEYUAN PHARMACEUTICAL CO LTD | 2014-11-19 | — | — | CN | claimed |
| CN-103819450-A | Novel method for preparing alogliptin benzoate | ZHEJIANG YONGNING PHARMA CO LTD | 2014-05-28 | — | — | CN | claimed |
| CN-103012287-A | Preparation method of 6-chlorine-3-methyl uracil | HEALTANG BIOTECH CO LTD | 2013-04-03 | — | — | CN | claimed |